Nasal Versus Buccal Oxygen Administration for Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-12-24

Study Completion Date

2021-04-06

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to compare to nasal and buccal oxygen administration in patients undergoing Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration .

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Assessment of the Efficacy of Tracheal Oxygen Administration During Bronchoscopy - a Phase II Trial

NCT01786642

Hypoxaemia

UNKNOWN

Aspiration in Acute Respiratory Failure Survivors

NCT02363686

Dysphagia

COMPLETED NA

Standard Oxygen Versus High Flow Nasal Cannula Oxygen Therapy in Patients With Acute Hypoxemic Respiratory Failure

NCT04468126

Acute Respiratory Failure Hypoxemic Respiratory Failure

COMPLETED NA

Comparison of Two Strategies of Oropharyngeal and Tracheal Suctioning in Mechanically Ventilated Patients

NCT01807884

Ventilator Acquired Pneumonia Aspiration

COMPLETED NA

Inspiratory Effort in COVID-19

NCT04666246

Acute Respiratory Failure Covid19

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Anesthesia for Endobronchial Ultrasound (EBUS) may be range from routine bronchoscopy sedation to general anesthesia. During sedation to EBUS increased duration of anesthesia and sedative dosing put patients at increased risk for hypoxic events. To avoid this, oxygen supplementation is mandatory. There are different techniques for oxygen supplementation during the procedure. At this study we will compare to nasal and buccal oxygen supplementations during EBUS.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lung Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

nasal oxygen supplementation group

supplemental oxygen will be administered with nasal cannula

Group Type ACTIVE_COMPARATOR

nasal oxygen

Intervention Type OTHER

Nasal cannula will be placed by the anesthesiologist. 6 l/ min of supplemental oxygen will be administered with nasal cannula.

buccal oxygen supplementation group

supplemental oxygen will be administered with Ring-Adair-Elwyn (RAE) tube

Group Type ACTIVE_COMPARATOR

buccal oxygen

Intervention Type OTHER

Ring-adair-elwyn (RAE) tube will be placed by the anesthesiologist. 6 l/ min of supplemental oxygen will be administered with RAE tube.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

nasal oxygen

Nasal cannula will be placed by the anesthesiologist. 6 l/ min of supplemental oxygen will be administered with nasal cannula.

Intervention Type OTHER

buccal oxygen

Ring-adair-elwyn (RAE) tube will be placed by the anesthesiologist. 6 l/ min of supplemental oxygen will be administered with RAE tube.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients ≥18 years of age
* body mass index (BMI) between 20 and 30
* American Society of Anesthesiologists physical status I-III

Exclusion Criteria

* congestive heart failure
* ischemic heart disease
* increased intracranial pressure
* known allergy or contraindication to study drugs (propofol, fentanyl, or midazolam)
* an anatomical feature precluding adequate positioning of the buccal device.

Minimum Eligible Age

18 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No